Carlson Capital Management Baxter International Inc Transaction History

Carlson Capital Management

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$63.83 - $80.0 $215,043 - $269,520	-3,369 Closed	0 $0
Q1 2022 May 24, 2022	SELL	$76.85 - $89.45 $845 - $983	-11 Reduced 0.33%	3,369 $261,000
Q4 2021 Jan 14, 2022	SELL	$74.57 - $87.19 $2,311 - $2,702	-31 Reduced 0.91%	3,380 $290,000
Q3 2021 Oct 12, 2021	BUY	$73.77 - $83.61 $4,942 - $5,601	67 Added 2.0%	3,411 $274,000
Q2 2021 Jul 12, 2021	BUY	$80.5 - $88.01 $2,012 - $2,200	25 Added 0.75%	3,344 $269,000
Q4 2020 Jan 11, 2021	SELL	$75.39 - $82.36 $150 - $164	-2 Reduced 0.06%	3,319 $271,000
Q3 2020 Oct 13, 2020	SELL	$78.33 - $90.73 $25,848 - $29,940	-330 Reduced 9.04%	3,321 $267,000
Q2 2020 Jul 13, 2020	BUY	$78.66 - $94.14 $287,187 - $343,705	3,651 New	3,651 $311,000
Q1 2018 Apr 20, 2018	SELL	$62.56 - $72.26 $207,761 - $239,975	-3,321 Closed	0 $0
Q3 2017 Oct 16, 2017	BUY	$59.5 - $64.61 $197,599 - $214,569	3,321	3,321 $208,000

1,008

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.6B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Carlson Capital Management, based on Form 13F filings with the SEC.

Stay updated on Carlson Capital Management with notifications on news.